Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial

Eric L Simpson; Marie-Louise A Schuttelaar; Sonja Molin; Margarida Gonçalo; Jart A F Oosterhaven; Xing-Hua Gao; Sumeet Uppal; Dimittri Delevry; Andrew Korotzer; Ana B Rossi

doi:10.1016/j.jaad.2025.12.079

Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial

Eric L Simpson
, Marie-Louise A Schuttelaar
, Sonja Molin
, Margarida Gonçalo
, Jart A F Oosterhaven
, Xing-Hua Gao
, Sumeet Uppal
, Dimittri Delevry
, Andrew Korotzer
, Ana B Rossi^*

^*Corresponding author for this work

Public Health Research (PHR)

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

Original language	English
Pages (from-to)	1513 - 1517
Number of pages	5
Journal	Journal of the American Academy of Dermatology
Volume	94
Issue number	5
Early online date	26-Dec-2025
DOIs	https://doi.org/10.1016/j.jaad.2025.12.079
Publication status	Published - May-2026

Access to Document

10.1016/j.jaad.2025.12.079Licence: CC BY

Dupilumab treatment improves health-related quality of lifeFinal publisher's version, 758 KBLicence: CC BY

Handle.net

Persistent link

Cite this

Simpson, E. L., Schuttelaar, M.-L. A., Molin, S., Gonçalo, M., Oosterhaven, J. A. F., Gao, X.-H., Uppal, S., Delevry, D., Korotzer, A., & Rossi, A. B. (2026). Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial. Journal of the American Academy of Dermatology, 94(5), 1513 - 1517. https://doi.org/10.1016/j.jaad.2025.12.079

Simpson, Eric L ; Schuttelaar, Marie-Louise A ; Molin, Sonja et al. / Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema) : results from a randomized placebo-controlled trial. In: Journal of the American Academy of Dermatology. 2026 ; Vol. 94, No. 5. pp. 1513 - 1517.

@article{cced0dce533546aabc4c3bdc50f2b1ac,

title = "Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial",

author = "Simpson, \{Eric L\} and Schuttelaar, \{Marie-Louise A\} and Sonja Molin and Margarida Gon{\c c}alo and Oosterhaven, \{Jart A F\} and Xing-Hua Gao and Sumeet Uppal and Dimittri Delevry and Andrew Korotzer and Rossi, \{Ana B\}",

year = "2026",

month = may,

doi = "10.1016/j.jaad.2025.12.079",

language = "English",

volume = "94",

pages = "1513 -- 1517",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "MOSBY-ELSEVIER",

number = "5",

}

Simpson, EL, Schuttelaar, M-LA, Molin, S, Gonçalo, M, Oosterhaven, JAF, Gao, X-H, Uppal, S, Delevry, D, Korotzer, A & Rossi, AB 2026, 'Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial', Journal of the American Academy of Dermatology, vol. 94, no. 5, pp. 1513 - 1517. https://doi.org/10.1016/j.jaad.2025.12.079

Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial. / Simpson, Eric L; Schuttelaar, Marie-Louise A; Molin, Sonja et al.
In: Journal of the American Academy of Dermatology, Vol. 94, No. 5, 05.2026, p. 1513 - 1517.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema)

T2 - results from a randomized placebo-controlled trial

AU - Simpson, Eric L

AU - Schuttelaar, Marie-Louise A

AU - Molin, Sonja

AU - Gonçalo, Margarida

AU - Oosterhaven, Jart A F

AU - Gao, Xing-Hua

AU - Uppal, Sumeet

AU - Delevry, Dimittri

AU - Korotzer, Andrew

AU - Rossi, Ana B

PY - 2026/5

Y1 - 2026/5

U2 - 10.1016/j.jaad.2025.12.079

DO - 10.1016/j.jaad.2025.12.079

M3 - Article

C2 - 41456798

SN - 0190-9622

VL - 94

SP - 1513

EP - 1517

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -

Simpson EL, Schuttelaar MLA, Molin S, Gonçalo M, Oosterhaven JAF, Gao XH et al. Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial. Journal of the American Academy of Dermatology. 2026 May;94(5):1513 - 1517. Epub 2025 Dec 26. doi: 10.1016/j.jaad.2025.12.079